Gabra H - Search Results

1

Cerebral sinus thrombosis and leptomeningeal carcinomatosis in a patient with ovarian cancer.

Li HK, Harding V, Williamson R, Blagden S, Gabra H, Agarwal R. Li HK, et al. Among authors: gabra h. J Clin Oncol. 2012 Jan 10;30(2):e19-20. doi: 10.1200/JCO.2011.38.1426. Epub 2011 Dec 12. J Clin Oncol. 2012. PMID: 22162572 No abstract available.

2

Future directions in the management of epithelial ovarian cancer.

Blagden S, Gabra H. Blagden S, et al. Among authors: gabra h. Future Oncol. 2008 Jun;4(3):403-11. doi: 10.2217/14796694.4.3.403. Future Oncol. 2008. PMID: 18518765 Review.

3

Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer.

Sharma R, Graham J, Mitchell H, Brooks A, Blagden S, Gabra H. Sharma R, et al. Among authors: gabra h. Br J Cancer. 2009 Mar 10;100(5):707-12. doi: 10.1038/sj.bjc.6604914. Epub 2009 Feb 17. Br J Cancer. 2009. PMID: 19223898 Free PMC article.

4

Promising molecular targets in ovarian cancer.

Blagden S, Gabra H. Blagden S, et al. Among authors: gabra h. Curr Opin Oncol. 2009 Sep;21(5):412-9. doi: 10.1097/CCO.0b013e32832eab1f. Curr Opin Oncol. 2009. PMID: 19553815 Review.

5

First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series.

Agarwal R, Gourley C, Perren TJ, Reed N, Parkin DE, Carty K, Rustin GJ, Gabra H, Paul J, Gore ME, Kaye SB; Scottish Gynecological Cancers Trials Group. Agarwal R, et al. Among authors: gabra h. Eur J Cancer. 2010 Jul;46(11):2020-6. doi: 10.1016/j.ejca.2010.03.006. Epub 2010 Apr 13. Eur J Cancer. 2010. PMID: 20395128 Clinical Trial.

6

The RNA binding protein Larp1 regulates cell division, apoptosis and cell migration.

Burrows C, Abd Latip N, Lam SJ, Carpenter L, Sawicka K, Tzolovsky G, Gabra H, Bushell M, Glover DM, Willis AE, Blagden SP. Burrows C, et al. Among authors: gabra h. Nucleic Acids Res. 2010 Sep;38(16):5542-53. doi: 10.1093/nar/gkq294. Epub 2010 Apr 29. Nucleic Acids Res. 2010. PMID: 20430826 Free PMC article.

7

HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.

Stronach EA, Alfraidi A, Rama N, Datler C, Studd JB, Agarwal R, Guney TG, Gourley C, Hennessy BT, Mills GB, Mai A, Brown R, Dina R, Gabra H. Stronach EA, et al. Among authors: gabra h. Cancer Res. 2011 Jul 1;71(13):4412-22. doi: 10.1158/0008-5472.CAN-10-4111. Epub 2011 May 13. Cancer Res. 2011. PMID: 21571862 Free PMC article.

8

Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer.

Sharma R, Graham J, Blagden S, Gabra H. Sharma R, et al. Among authors: gabra h. BMC Cancer. 2011 Jul 11;11:289. doi: 10.1186/1471-2407-11-289. BMC Cancer. 2011. PMID: 21745358 Free PMC article. Clinical Trial.

9

DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance.

Stronach EA, Chen M, Maginn EN, Agarwal R, Mills GB, Wasan H, Gabra H. Stronach EA, et al. Among authors: gabra h. Neoplasia. 2011 Nov;13(11):1069-80. doi: 10.1593/neo.111032. Neoplasia. 2011. PMID: 22131882 Free PMC article.

10

A study of symptoms described by ovarian cancer survivors.

Stavraka C, Ford A, Ghaem-Maghami S, Crook T, Agarwal R, Gabra H, Blagden S. Stavraka C, et al. Among authors: gabra h. Gynecol Oncol. 2012 Apr;125(1):59-64. doi: 10.1016/j.ygyno.2011.12.421. Epub 2011 Dec 9. Gynecol Oncol. 2012. PMID: 22155797

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

217 results

Search Page